Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

Video Game Performers Will Strike Over AI concerns

Hollywood’s video game performers are going on strike, throwing part of the entertainment industry into another work stoppage.

Widespread Gains Send Wall Street Higher To Close a Shaky week

U.S. stocks climbed Friday to close out a bumpy week dominated by sharp, market-cleaving swings.

Tech Stocks’ Terrible, Horrible, No Good, Very Bad Week

Pretty much all the tech stocks driving the market were looking shaky—and they weren't the only ones.

Small Stocks Are About to Take over? Wall Street Is Unconvinced...

Some of the smallest stocks on Wall Street have shown much more life recently. but professional investors still aren’t convinced.

Global Shares Tumble after Big Tech’s Wipeout on Wall Street

Global shares have dropped as pessimism set in over Wall Street's nose-dive related to Big Tech's pullback.

Domino's Q2: Strong Growth Amidst Inflation and Future Challenges

Domino’s Pizza reported a 7.1% revenue rise to $1.1B amid value meal competition and inflation. Q3 may slow, with caution on growth and consumer spending.

Load More